Literature DB >> 1608493

Epidemiology of spinal muscular atrophies in a sample of the Italian population.

M L Mostacciuolo1, G A Danieli, C Trevisan, E Müller, C Angelini.   

Abstract

In the course of an epidemiological survey in four provinces of Veneto (northeastern Italy) 67 spinal muscular atrophy (SMA) cases (types I, II and III) were recorded. The survey spanned the period 1960-1983 and involved 859,891 consecutive live-born infants in a population of 2,635,800 inhabitants. The overall prevalence at birth for SMA types I, II and III was 7.8/100,000 live births. Type I alone accounted for 4.1/100,000 live births. If the hypothesis that SMA types I, II and III are clinical manifestations of allelic mutations is assumed, the mutation rate would be about 70 x 10(-6) and the frequency of the heterozygotes 1 in 57.

Entities:  

Mesh:

Year:  1992        PMID: 1608493     DOI: 10.1159/000110905

Source DB:  PubMed          Journal:  Neuroepidemiology        ISSN: 0251-5350            Impact factor:   3.282


  11 in total

1.  Riluzole pharmacokinetics in young patients with spinal muscular atrophy.

Authors:  Chadi Abbara; Brigitte Estournet; Lucette Lacomblez; Benedicte Lelièvre; Amal Ouslimani; Blandine Lehmann; Louis Viollet; Annie Barois; Bertrand Diquet
Journal:  Br J Clin Pharmacol       Date:  2011-03       Impact factor: 4.335

2.  Carrier screening for spinal muscular atrophy in Italian population.

Authors:  Francesco Calì; Giuseppa Ruggeri; Valeria Chiavetta; Carmela Scuderi; Sebastiano Bianca; Chiara Barone; Alda Ragalmuto; Pietro Schinocca; Girolamo Aurelio Vitello; Valentino Romano; Sebastiano Musumeci
Journal:  J Genet       Date:  2014-04       Impact factor: 1.166

3.  Efficacy and Safety of Valproic Acid for Spinal Muscular Atrophy: A Systematic Review and Meta-Analysis.

Authors:  Abdelrahman Elshafay; Truong Hong Hieu; Mohamed Fahmy Doheim; Mahmoud Attia Mohamed Kassem; Mohammed Fathi ELdoadoa; Sarah Keturah Holloway; Heba Abo-Elghar; Kenji Hirayama; Nguyen Tien Huy
Journal:  CNS Drugs       Date:  2019-03       Impact factor: 5.749

4.  Prospective study of gross motor development in children with SMA type II.

Authors:  R Bono; M Inverno; G Botteon; E Iotti; M Estienne; A Berardinelli; G Lanzi; E Fedrizzi
Journal:  Ital J Neurol Sci       Date:  1995-05

5.  Chronic childhood spinal muscular atrophy in Germany (West-Thüringen)--an epidemiological study.

Authors:  A Thieme; B Mitulla; F Schulze; A W Spiegler
Journal:  Hum Genet       Date:  1994-03       Impact factor: 4.132

6.  Genetic epidemiology of congenital muscular dystrophy in a sample from north-east Italy.

Authors:  M L Mostacciuolo; M Miorin; F Martinello; C Angelini; P Perini; C P Trevisan
Journal:  Hum Genet       Date:  1996-03       Impact factor: 4.132

7.  Evaluation of muscle strength and motor abilities in children with type II and III spinal muscle atrophy treated with valproic acid.

Authors:  Illora A Darbar; Paulo G Plaggert; Maria Bernadete D Resende; Edmar Zanoteli; Umbertina C Reed
Journal:  BMC Neurol       Date:  2011-03-24       Impact factor: 2.474

Review 8.  The ties that bind: functional clusters in limb-girdle muscular dystrophy.

Authors:  Elisabeth R Barton; Christina A Pacak; Whitney L Stoppel; Peter B Kang
Journal:  Skelet Muscle       Date:  2020-07-29       Impact factor: 4.912

9.  Multisite Evaluation and Validation of a Sensitive Diagnostic and Screening System for Spinal Muscular Atrophy that Reports SMN1 and SMN2 Copy Number, along with Disease Modifier and Gene Duplication Variants.

Authors:  John N Milligan; Jessica L Larson; Stela Filipovic-Sadic; Walairat Laosinchai-Wolf; Ya-Wen Huang; Tsang-Ming Ko; Kristin M Abbott; Henny H Lemmink; Minna Toivonen; Johanna Schleutker; Caren Gentile; Vivianna M Van Deerlin; Huiping Zhu; Gary J Latham
Journal:  J Mol Diagn       Date:  2021-03-30       Impact factor: 5.341

Review 10.  Prevalence, incidence and carrier frequency of 5q-linked spinal muscular atrophy - a literature review.

Authors:  Ingrid E C Verhaart; Agata Robertson; Ian J Wilson; Annemieke Aartsma-Rus; Shona Cameron; Cynthia C Jones; Suzanne F Cook; Hanns Lochmüller
Journal:  Orphanet J Rare Dis       Date:  2017-07-04       Impact factor: 4.123

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.